Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure

Study limitation reported by the research below: “Individual molecular subgroup analyses were underpowered; alteration-specific conclusions (e.g., FGFR2, IDH1) cannot be reliably drawn from this dataset.”